The BASIS study was a phase 3, open-label, multicenter study that aimed to test the efficacy of marstacimab in patients with severe hemophilia of factor VIII activity of less than 1% or moderately ...

Today, a coalition of leading non-partisan, non-profit patient advocacy organizations issued a sharp rebuke following Senate passage of H.R. 1, warning of devastating coverage losses nationwide.

Findings indicate that women and men with rheumatoid arthritis have different treatment responses to anti-TNF therapy. Holly Webster Research Highlights 02 Apr 2025 Nature Reviews Rheumatology ...

Omega-3s are fatty acids that may alleviate inflammation and joint pain. Some research has shown that these supplements may reduce stiffness in people with arthritis and also combat joint pain ...

Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...